Internal Medicine, Nephrology · San Jose, CA
NPI
1942233580
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
200 Jose Figueres Ave, Suite 255
San Jose, CA, 95116
Phone (408) 223-7474
Groups this clinician bills Medicare through
Medicare paid, 2024
$516K
4,503 services
Medicare patients, 2024
1,023
Average age 77
Drug cost, 2024
$2.3M
10,136 prescriptions
Company payments, 2025
$125
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Padma Yarlagadda was code 99232 (hospital e&m - subsequent), 1,737 times for 380 patients. In total Padma Yarlagadda billed 4,503 services in 12 codes, and Medicare paid $516K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,737 | 380 | $70.29 | $122K |
| 99213 Office E&M - Established | Office | 1,392 | 525 | $51.82 | $72K |
| 90960 ESRD Related Services (not dialysis) | Office | 602 | 95 | $322.02 | $194K |
| 99222 Hospital E&M - Initial | Facility | 333 | 293 | $115.87 | $39K |
| 90961 ESRD Related Services (not dialysis) | Office | 209 | 89 | $268.78 | $56K |
| 99204 Office E&M - New | Office | 103 | 103 | $133.11 | $14K |
| 90962 ESRD Related Services (not dialysis) | Office | 52 | 26 | $187.70 | $9,760 |
| 99214 Office E&M - Established | Office | 11 | 11 | $117.02 | $1,287 |
By year: 2022 $651K for 5,291 services; 2023 $597K for 4,891 services; 2024 $516K for 4,503 services.
Medicare prescription drug claims, 2024
In 2024, the drug Padma Yarlagadda prescribed most often to Medicare patients was Losartan Potassium, with 844 prescriptions and refills. In total Padma Yarlagadda wrote 10,136 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 844 | 2,126 | 272 | $7,784 |
| Amlodipine Besylate Generic | 817 | 1,941 | 279 | $6,155 |
| Jardiance Empagliflozin | 483 | 983 | 140 | $550K |
| Atorvastatin Calcium Generic | 376 | 1,006 | 133 | $4,227 |
| Allopurinol Generic | 363 | 998 | 126 | $4,489 |
| Metoprolol Succinate Generic | 354 | 864 | 119 | $4,703 |
| Vascepa Icosapent Ethyl | 341 | 602 | 93 | $133K |
| Furosemide Generic | 291 | 621 | 95 | $1,172 |
| Ezetimibe Generic | 285 | 756 | 97 | $6,543 |
| Hydralazine Hcl Generic | 282 | 561 | 94 | $2,865 |
| Farxiga Dapagliflozin Propanediol | 246 | 491 | 78 | $268K |
| Calcitriol Generic | 240 | 611 | 75 | $1,235 |
| Sevelamer Carbonate Generic | 227 | 481 | 78 | $78K |
| Icosapent Ethyl Generic | 225 | 428 | 79 | $48K |
| Omega-3 Acid Ethyl Esters Generic | 216 | 426 | 65 | $11K |
Brand drugs: 2,339 claims; generic drugs: 7,749 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Padma Yarlagadda $125 ($125 in general payments such as food, travel and fees) from 1 company. The largest payer was Akebia Therapeutics Inc with $125.
| Company | Payments | Amount |
|---|---|---|
| Akebia Therapeutics Inc AKBA | 1 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.